Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Rarick Lisa Dale, Director. Officer active across 2 companies, notably Evofem Biosciences, Inc.. Aggregated, 2 filings have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €10k. History available since 11 June 2021. The latest transaction was disclosed on 11 June 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Lisa Dale Rarick is a Board Member at Evofem Biosciences, Inc. She provides strategic insight to the board, contributing to the direction and decision-making of the company. With her expertise in the life sciences field, Lisa Dale Rarick helps guide initiatives that strengthen Evofem's market position. Her role is essential in ensuring that the company remains competitive and compliant with regulatory requirements.